Literature DB >> 33717192

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults.

Richard Baguma1, Stanley Kimbung Mbandi1, Miguel J Rodo1, Mzwandile Erasmus1, Jonathan Day1, Lebohang Makhethe1, Marwou de Kock1, Michele van Rooyen1, Lynnett Stone1, Nicole Bilek1, Marcia Steyn1, Hadn Africa1, Fatoumatta Darboe1, Novel N Chegou2, Gerard Tromp2, Gerhard Walzl2, Mark Hatherill1, Adam Penn-Nicholson1, Thomas J Scriba1.   

Abstract

The risk of progression from Mycobacterium tuberculosis (M.tb) infection to active tuberculosis (TB) disease varies markedly with age. TB disease is significantly less likely in pre-adolescent children above 4 years of age than in very young children or post-pubescent adolescents and young adults. We hypothesized that pro-inflammatory responses to M.tb in pre-adolescent children are either less pronounced or more regulated, than in young adults. Inflammatory and antimicrobial mediators, measured by microfluidic RT-qPCR and protein bead arrays, or by analyzing published microarray data from TB patients and controls, were compared in pre-adolescent children and adults. Multivariate analysis revealed that M.tb-uninfected 8-year-old children had lower levels of myeloid-associated pro-inflammatory mediators than uninfected 18-year-old young adults. Relative to uninfected children, those with M.tb-infection had higher levels of similar myeloid inflammatory responses. These inflammatory mediators were also expressed after in vitro stimulation of whole blood from uninfected children with live M.tb. Our findings suggest that myeloid inflammation is intrinsically lower in pre-pubescent children than in young adults. The lower or more regulated pro-inflammatory responses may play a role in the lower risk of TB disease in this age group.
Copyright © 2021 Baguma, Mbandi, Rodo, Erasmus, Day, Makhethe, de Kock, van Rooyen, Stone, Bilek, Steyn, Africa, Darboe, Chegou, Tromp, Walzl, Hatherill, Penn-Nicholson and Scriba.

Entities:  

Keywords:  age; anti-mycobacterial immunity; inflammation; pediatric; tuberculosis

Year:  2021        PMID: 33717192      PMCID: PMC7947716          DOI: 10.3389/fimmu.2021.639965

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  53 in total

1.  Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections.

Authors:  David M Tobin; Francisco J Roca; Sungwhan F Oh; Ross McFarland; Thad W Vickery; John P Ray; Dennis C Ko; Yuxia Zou; Nguyen D Bang; Tran T H Chau; Jay C Vary; Thomas R Hawn; Sarah J Dunstan; Jeremy J Farrar; Guy E Thwaites; Mary-Claire King; Charles N Serhan; Lalita Ramakrishnan
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

2.  Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis.

Authors:  Timothy E Sweeney; Lindsay Braviak; Cristina M Tato; Purvesh Khatri
Journal:  Lancet Respir Med       Date:  2016-02-20       Impact factor: 30.700

Review 3.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

Review 4.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

Authors:  B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

5.  Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines.

Authors:  Gerlinde Obermoser; Scott Presnell; Kelly Domico; Hui Xu; Yuanyuan Wang; Esperanza Anguiano; Luann Thompson-Snipes; Rajaram Ranganathan; Brad Zeitner; Anna Bjork; David Anderson; Cate Speake; Emily Ruchaud; Jason Skinner; Laia Alsina; Mamta Sharma; Helene Dutartre; Alma Cepika; Elisabeth Israelsson; Phuong Nguyen; Quynh-Anh Nguyen; A Carson Harrod; Sandra M Zurawski; Virginia Pascual; Hideki Ueno; Gerald T Nepom; Charlie Quinn; Derek Blankenship; Karolina Palucka; Jacques Banchereau; Damien Chaussabel
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

Review 6.  Tuberculosis Vaccine Development: Progress in Clinical Evaluation.

Authors:  Suraj B Sable; James E Posey; Thomas J Scriba
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

Review 7.  Moving tuberculosis vaccines from theory to practice.

Authors:  Peter Andersen; Thomas J Scriba
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

8.  Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response.

Authors:  Selvakumar Subbian; Liana Tsenova; Guibin Yang; Paul O'Brien; Sven Parsons; Blas Peixoto; Leslie Taylor; Dorothy Fallows; Gilla Kaplan
Journal:  Open Biol       Date:  2011-12       Impact factor: 6.411

Review 9.  The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?

Authors:  James A Seddon; Silvia S Chiang; Hanif Esmail; Anna K Coussens
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

10.  Capturing heterogeneity in gene expression studies by surrogate variable analysis.

Authors:  Jeffrey T Leek; John D Storey
Journal:  PLoS Genet       Date:  2007-08-01       Impact factor: 5.917

View more
  4 in total

1.  A Novel Para-Amino Salicylic Acid Magnesium Layered Hydroxide Nanocomposite Anti-Tuberculosis Drug Delivery System with Enhanced in vitro Therapeutic and Anti-Inflammatory Properties.

Authors:  Bullo Saifullah; Palanisamy Arulselvan; Mohamed E El Zowalaty; Woan Sean Tan; Sharida Fakurazi; Thomas J Webster; Rabia Baby; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2021-10-15

2.  IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort.

Authors:  Timothy F Spracklen; Simon C Mendelsohn; Claire Butters; Heidi Facey-Thomas; Raphaella Stander; Debbie Abrahams; Mzwandile Erasmus; Richard Baguma; Jonathan Day; Christiaan Scott; Liesl J Zühlke; George Kassiotis; Thomas J Scriba; Kate Webb
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

Review 3.  Transcriptomics for child and adolescent tuberculosis.

Authors:  Myrsini Kaforou; Claire Broderick; Ortensia Vito; Michael Levin; Thomas J Scriba; James A Seddon
Journal:  Immunol Rev       Date:  2022-07-12       Impact factor: 10.983

Review 4.  The Impact of Tuberculosis on the Well-Being of Adolescents and Young Adults.

Authors:  Patricia Moscibrodzki; Leslie A Enane; Graeme Hoddinott; Meredith B Brooks; Virginia Byron; Jennifer Furin; James A Seddon; Lily Meyersohn; Silvia S Chiang
Journal:  Pathogens       Date:  2021-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.